Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion type Assertion NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_head.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion description "[The expression of the oxytocin (OT) receptor (OTR) in breast cancer was studied using newly established anti-OTR monoclonal antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_provenance.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion evidence source_evidence_literature NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_provenance.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion SIO_000772 8593829 NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_provenance.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion wasDerivedFrom befree-20140225 NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_provenance.
- NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_assertion wasGeneratedBy ECO_0000203 NP688865.RAweRb9rDrdO7oin7ze3hJ6lu-ZPzt-5R3iL-YNMxWE2k130_provenance.